首页>>国际

重庆16个区县部分地区出现人畜饮水困难和农作物因旱受灾

2022-08-10 11:56:37 | 来源:兰州市新闻网
小字号

  中新网重庆8月9日电 (记者 刘相琳)记者9日从重庆市应急局得悉,该市持续呈现两轮年夜规模延续性高温少雨气候,导致16个区县部门地域呈现人畜饮水坚苦和农作物因旱受灾。   据重庆景象形象部分测报,7月以来,重庆全市平均高温日数24.4天,为1961年以来第2多,全市平均降水量98.1毫米,较终年同期(204.6毫米)显著偏少5成。重庆全市泥土耕耘层(0至20厘米)平均泥土相对湿度51.6%,达轻度干旱品级,中西部年夜部地域和东部的梁平、云阳、奉节、巫溪、石柱、黔江、酉阳等区县部门地域泥土干旱已达中到重度品级。   据重庆水利部分统计,该市水利工程现实蓄水量25.81亿立方米,占应蓄水量的69.06%,此中江津、綦江、云阳、奉节、武隆、秀山、酉阳等7个区县占比不到65%,忠县、城口、开州等3个区县占比不到50%。今朝,黔江、江津、合川、永川、南川、綦江、潼南、铜梁、荣昌、梁平、武隆、开州、奉节、巫山、巫溪、彭水等16个区县部门地域已呈现人畜饮水坚苦和农作物因旱受灾,此中永川、巫山、彭水因旱受灾生齿比例跨越3%,武隆因旱受灾生齿比例跨越5%。   经谈判研判,估计到8月中旬,重庆仍将保持年夜规模高强度高温气候,局地可达42至44摄氏度,全市人畜饮水坚苦和农作物因旱受灾规模将进一步扩年夜,水利工程蓄水可能锐减且没法获得有用弥补,高温热害及干旱影响进一步加重;全市8月气温偏高,降水偏少,高温天数较终年略偏多,部门地域景象形象干旱侧重。   按照《重庆市防汛抗旱应急预案》,重庆市防汛抗旱批示部决议于8月9日15时发布干旱灾难黄色预警,并启动全市抗旱Ⅳ级应急响应。要求相干区县、市防指成员单元要切实落实抗旱责任制,正确掌控高温旱情成长情势,强化同一批示,兼顾做好疫情防控与抗旱工作,安身于抗年夜旱、抗长旱,采纳有针对性的应对办法,尽早脱手、普遍策动、综合施策,最年夜限度削减旱灾损掉,全力保障正常糊口用水和饮水平安。(完) 【编纂:苏亦瑜】

(责编:adkin)

分享让更多人看到

附近美女 过夜

因未按规定开展客户身份重新识别等 农行甘肃分行被罚136.15万元

2022-08-10 11:45:37 | 来源:宁波市新闻网
小字号

  8月10日动静,中国人平易近银行兰州中间支行行政惩罚信息公然表显示,中国农业银行股分有限公司甘肃省份行因未按划定展开客户身份从头辨认等,被监管正告并惩罚款136.15万元。  具体背规事实以下:  1、反洗钱营业方面存在未按划定展开客户身份延续辨认;未按划定展开客户身份从头辨认;未按划定展开客户风险品级划分、调剂和审核工作;未按划定对高风险客户采纳强化辨认办法;未按划定陈述年夜额买卖陈述或可疑买卖陈述的背规行动。  2、货泉金银营业方面存在对外支出现金中有同化不宜畅通人平易近币;现金从业人员营业常识不足,判定和抉剔假币的专业能力有待提高;自助纸币辨别机具辨别能力达不到要求等背规行动。  3、金融消费权益庇护营业方面存在操纵手艺手段,强迫消费者接管金融办事;未对投诉进行准确分类并按时报送相干信息;投诉数据存在漏报等背规行动。  别的,相干责任人姚建斌被罚款3.31万元;毛浓鹤被罚款2.13万元;张滨被罚款1.32万元。

(责编:adkin)

分享让更多人看到

Asia Cell & Gene Therapy Innovation Summit 2022
  • #CGT Asia 2022
  • August 9th-10th
  • Shanghai China

Asia Cell & Gene Therapy Innovation Summit 2022

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Cell Therapy, Gene Therapy, Innovative Therapy, Next Generation Oncolytic Virus, End to End Development, CDMO, CRO, Regulation, IND Application, GLP, Clinical Trail Design, Continuous Production Process, GMP, Immunomodulation, Viral Vectors, High-Throughput Screening, Transfection, Combination Therapy, IVD, Digital PCR, CRISPR/CAS9 Gene Editing, Humanized Animal models, mRNA Tumor Vaccines, Nanoantibody, BsAbs, Customization Manufacturing, Tumor Microenvironment, Stem Cell Therapy, Recombinant Protein, Targets

Event Highlights

Cell Therapy Industrialization and Commercialization Module Strategy

TCR-T Therapy Market Prospects and Development Trends

Targets Selection and Direction of TCR-T Therapeutic Products

Development Key Points of Universal CAR-NK Cell Therapy Products

iPSC Personalized Diagnosis and Treatment and Application

Research and Development of mRNA Drug and Delivery Vector Technology

Viral Vector Process and Optimization Plan

Difficulty in the Development of Gene Therapy Drugs for Rare Diseases

Current Status of Circular RNA R&D

Who Should Attend

Biopharmaceutical CompaniesPre-Clinical R&DClinical R & DVaccine/Antibody CompaniesCell Therapy CompaniesGene Therapy CompaniesScientific Research InstitutesBiotechnology CompaniesLaboratory Equipment SuppliersDrug TestingAnalytical ServicesProduction Solution Providers (Upstream, Downstream) Life Science and Analytical EquipmentDiagnostic and Testing EquipmentExternal AuthorizationProtein Drugs CompaniesContract Service Providers (CRO, CMO, CDMO) Import and Export EnterprisesHVAC Facilities and Cleanroom Equipment SuppliersGovernment Representatives/Trading InstitutionsPreparation MachineryPharmaceutical EngineeringLaw and Regulation FirmsDrug Delivery System ManufacturersThird Party Logistics ProvidersAutomation/RobotCold Chain Packaging CompaniesPackaging MachineryIndustrial ParksLaboratory ServicesLaboratory/Biochemical/Analytical InstrumentsFine Chemical ManufacturersEnvironmental ProtectionIntermediate ManufacturersRegulatory ServicesSupply ChainNew Drug R & D CompaniesConsultant Companies


Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show


Speakers

Dr. Xingwang XIE
Dr. Xingwang XIE

CEO

Corregene

Dr. Guojie YE
Dr. Guojie YE

CSO

EXEGENESIS BIO

Dr. Jinghui DOU
Dr. Jinghui DOU

CSO

TriApex Laboratories Co. LTD

Dr. Wenqiang YU
Dr. Wenqiang YU

Senior PI

Institutes of Biomedical Sciences Fudan University

Yan CHANG
Yan CHANG

President

INNOSTAR - National Shanghai Center for New Drug Safety Evaluation and Research

Dr. Xinpo JIANG
Dr. Xinpo JIANG

Associate Vice President, R&D, Catalog Product

GenScript

Mr. Hongdong YU
Mr. Hongdong YU

Director of Biological Culture Scenario

Haier Biomedical

Xiaochun Wan
Xiaochun Wan

CEO

Shenzhen BinDeBio Ltd.

Kangjian ZHANG
Kangjian ZHANG

Co-Founder, Director and GM

Yuansong Bio

Dr. Andrew LIN
Dr. Andrew LIN

Founder & CEO

Lingyi Biotherapeutics Co. Ltd

Mo MA
Mo MA

CEO

Shenzhen Eureka Biotechnology Co., Limited

Dr. Jinqiao WAN
Dr. Jinqiao WAN

Vice President of R&D Chemistry Center

HitGen Inc.

Chunying Li
Chunying Li

Technical Application Liaison, China

Mission Bio

Hongjiu DAI
Hongjiu DAI

CEO

Nanjing Kaedi Biotherapeutics

Prof. Evelyne Yehudit Bischof
Prof. Evelyne Yehudit Bischof

Professor Doctor

Shanghai University of Medicine and Health Sciences

Yongzhen LIU
Yongzhen LIU

Deputy Director of Center for Drug Safety Evaluation

Shanghai Institute of Materia Medica

Ryan CAWOOD
Ryan CAWOOD

Chief Scientific Officer

WuXi Advanced Therapies

 Lei ZHANG
Lei ZHANG

R&D VP

Neukio Biotherapeutics

Jimin GAO
Jimin GAO

Professor

Wenzhou Medical University

Ke ZHANG
Ke ZHANG

Chief Scientific Officer

SCG Cell

Yun YANG
Yun YANG

CTO

CirCode Bio

Yang WANG
Yang WANG

Director of Research and Development

Wuhan Binhui Biopharmaceutical

Xiaoxi XU
Xiaoxi XU

Director of In Vitro

Crown Bioscience

Mark FANG
Mark FANG

CQO

Shanghai Zhimi Medical Technology

Adam ZHAO
Adam ZHAO

President

AnlongBio

Yunxiang ZHU
Yunxiang ZHU

Vice President

CANbridge Pharma

Frank GAO
Frank GAO

Chief Strategy Officer

BRL Medicine

Tianhong XU
Tianhong XU

CEO

Base Therapeutics

Emily TAN
Emily TAN

Chief Operating Officer

Bennu Biotherapeutics

Fred MAO
Fred MAO

Partner & Managing Director

Frost & Sullivan

Yarong LIU
Yarong LIU

Founder

Grit Biotechnology

Lei SUN
Lei SUN

CTO

GeneMind

John LU
John LU

President & CEO

HebeCell

Yi ZHU
Yi ZHU

Chief Executive Officer

Hillgene

Grace Zhou
Grace Zhou

CEO

ImmVira Pharma

Xiaoqi QI
Xiaoqi QI

Associate Regional Marketing Manager

10x Genomics

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

( Slots Limited)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at CGT Asia our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Media Partners

今日头条
搜狐
药智网
医谷网
CPHI制药在线
会会药咖
镁客网
化学加
人民医生网
研发客
肽度
大健康派
生物探索
药源网
基因线上
转化医学网
现代健康网
医药健闻
中国制药设备网
环球财经
商业观察网
医诺医学
美通社
动脉网
医疗器械创新网
化学网
中国仪器批发网
再生医学
盖德化工网
大健康网
阿仪网
张通社
测序宝
基因君
51健康网
中国健康咨询网
爱爱医
来宝网
露森科研
生物通
医学信息
中国生物器材网
分析测试百科网
全球医学会议网

Related Meetings

Presentation, Sponsorship and Exhibition

Gina Xu

Tel:86 21 5893 3801 ext.805

Mob:13601679417

Email:gina.xu@taaslabs.com

Media and Marketing Cooperation

Koala Yan

Tel:86 215893 3801 ext. 811

Mob:13341683667

Email:koala.yan@taaslabs.com

Know More Hot and informative Medical News on Biopharma, Cell& Gene etc. Follow Us Now